These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38512618)

  • 81. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
    Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
    Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound.
    Luciani ML; Pediconi F; Telesca M; Vasselli F; Casali V; Miglio E; Passariello R; Catalano C
    Radiol Med; 2011 Sep; 116(6):886-904. PubMed ID: 21293943
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography-a prospective study.
    Gweon HM; Eun NL; Youk JH; Jeong J; Bae SJ; Ahn SG; Kim JA; Son EJ
    Eur Radiol; 2022 Feb; 32(2):815-821. PubMed ID: 34342691
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Contrast-enhanced Mammography versus MR Imaging of the Breast.
    Mann RM; Longo V
    Radiol Clin North Am; 2024 Jul; 62(4):643-659. PubMed ID: 38777540
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Characterization of True and False Positive Findings on Contrast-Enhanced Mammography.
    Phillips J; U Achibiri J; Kim G; Quintana LM; J Mehta R; S Mehta T
    Acad Radiol; 2022 Nov; 29(11):1672-1681. PubMed ID: 35190261
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Breast masses with rim enhancement on contrast-enhanced mammography: morphological and enhancement features for diagnosis and differentiation of benign and malignant.
    Wen C; Wang S; Ma M; Xu Z; Zeng F; Zeng H; Liao X; He Z; Xu W; Chen W
    Br J Radiol; 2024 May; 97(1157):1016-1021. PubMed ID: 38521539
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
    Zhang C; Kosiorek HE; Patel BK; Pockaj BA; Ahmad SB; Cronin PA
    Ann Surg Oncol; 2022 Oct; 29(10):6207-6212. PubMed ID: 35831526
    [TBL] [Abstract][Full Text] [Related]  

  • 90. State-of-the-art for contrast-enhanced mammography.
    Covington MF; Salmon S; Weaver BD; Fajardo LL
    Br J Radiol; 2024 Mar; 97(1156):695-704. PubMed ID: 38374651
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis.
    Fueger BJ; Clauser P; Kapetas P; Pötsch N; Helbich TH; Baltzer PAT
    Breast; 2021 Apr; 56():53-60. PubMed ID: 33618160
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical Utility of Real-Time MR-Navigated Ultrasound with Supine Breast MRI for Suspicious Enhancing Lesions Not Identified on Second-Look Ultrasound.
    Kang DK; Jung Y; Han S; Kim JY; Kim TH
    Ultrasound Med Biol; 2017 Feb; 43(2):412-420. PubMed ID: 27780660
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
    Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
    Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
    AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
    [No Abstract]   [Full Text] [Related]  

  • 95. Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone.
    Chudgar AV; Conant EF; Weinstein SP; Keller BM; Synnestvedt M; Yamartino P; McDonald ES
    Clin Radiol; 2017 Jul; 72(7):573-579. PubMed ID: 28318506
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
    Blankenburg M; Sánchez-Collado I; Soyemi BO; Åkerborg Ö; Caleyachetty A; Harris J; Morris E; Newstead G; Lobig F
    J Med Econ; 2023; 26(1):850-861. PubMed ID: 37278659
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
    Bicchierai G; Amato F; Vanzi B; De Benedetto D; Boeri C; Vanzi E; Di Naro F; Bianchi S; Cirone D; Cozzi D; Miele V; Nori J
    Breast; 2020 Dec; 54():15-24. PubMed ID: 32889303
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.
    Rong X; Kang Y; Xue J; Han P; Li Z; Yang G; Shi G
    Eur Radiol; 2022 Nov; 32(11):7439-7447. PubMed ID: 35639141
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preoperative breast cancer staging with multi-modality imaging and surgical outcomes.
    Mariscotti G; Durando M; Tagliafico A; Campanino PP; Bosco D; Casella C; Bussone R; Ala A; Castellano I; Sapino A; Bergamasco L; Fonio P; Houssami N
    Eur J Radiol; 2020 Jan; 122():108766. PubMed ID: 31809942
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.